|
Azvolinsky, Anna; Giresi, Paul G; Lieb, Jason D et al. (2009) Highly transcribed RNA polymerase II genes are impediments to replication fork progression in Saccharomyces cerevisiae. Mol Cell 34:722-34
|
|
Azvolinsky, Anna; Dunaway, Stephen; Torres, Jorge Z et al. (2006) The S. cerevisiae Rrm3p DNA helicase moves with the replication fork and affects replication of all yeast chromosomes. Genes Dev 20:3104-16
|
|
Fefer, A; Robinson, N; Benyunes, M C et al. (1997) Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. Cancer J Sci Am 3 Suppl 1:S48-53
|
|
Gold, P J; Thompson, J A; Markowitz, D R et al. (1997) Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2. Cancer J Sci Am 3 Suppl 1:S85-91
|
|
Thompson, J A; Gold, P J; Markowitz, D R et al. (1997) Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma. Cancer J Sci Am 3 Suppl 1:S29-34
|
|
Robinson, N; Benyunes, M C; Thompson, J A et al. (1997) Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplant 19:435-42
|
|
Thompson, J A; Bianco, J A; Benyunes, M C et al. (1994) Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma. Cancer Res 54:3436-41
|
|
Neubauer, M A; Benyunes, M C; Thompson, J A et al. (1994) Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 13:311-6
|
|
Thompson, J A; Benyunes, M C; Bianco, J A et al. (1993) Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells. Semin Oncol 20:46-51
|
